Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Sales | 211 | 246 | 480 | 297 | 143 |
| Gross Profit | 211 | 246 | 480 | 297 | 143 |
| Operating Expenses | 505 | 761 | 820 | 607 | 784 |
| Operating Income | -294 | -516 | -340 | -310 | -641 |
| Interest Expense | 50 | 38 | 83 | 31 | 27 |
| Other Income | 0 | 0 | 44 | 0 | 0 |
| Pre-tax Income | -344 | -554 | -379 | -340 | -668 |
| Net Income Continuous | -344 | -554 | -379 | -340 | -668 |
| Net Income | $-344 | $-554 | $-379 | $-340 | $-668 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.01 | -0.02 | -0.03 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.01 | -0.02 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| EBITDA(a) | $-286 | $-508 | $-499 | $-303 | $-632 |